832342 -OEChem-07250805153D 12 12 0 1 0 0 0 0 0999 V2000 -3.0200 51.4150 213.5590 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5930 55.1510 212.3090 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.3500 54.6190 212.3450 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.6760 52.4700 211.9830 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.8180 50.6980 214.1670 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.4230 51.1220 212.1730 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.1110 54.1030 213.0970 C 0 0 1 0 0 0 0 0 0 0 0 0 -3.4280 53.5670 212.5310 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.1150 52.9460 213.2440 C 0 0 1 0 0 0 0 0 0 0 0 0 -3.9470 52.4990 213.5110 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.7430 51.8050 214.0690 C 0 0 1 0 0 0 0 0 0 0 0 0 -5.3880 52.0490 213.2330 C 0 0 0 0 0 0 0 0 0 0 0 0 1 10 1 0 0 0 0 1 11 1 0 0 0 0 2 7 1 0 0 0 0 3 8 1 0 0 0 0 4 9 1 0 0 0 0 5 11 1 0 0 0 0 6 12 1 0 0 0 0 7 8 1 0 0 0 0 7 9 1 0 0 0 0 8 10 1 0 0 0 0 9 11 1 0 0 0 0 10 12 1 0 0 0 0 M END > 0 > 0 > 832342 > 6 > MMDB > BMA > 27406.16 > PDB Accession Code 1S78 Insights Into Erbb Signaling From The Structure Of The Erbb2-Pertuzumab Complex Transferase Insights Into Erbb Signaling From The Structure Of The Erbb2-Pertuzumab Complex Receptor-Antibody Complex, Fab Fragment, Cysteine-Rich Domain, Leucine-Rich Repeat Mol_id: 1; Molecule: Receptor Protein-Tyrosine Kinase Erbb-2; Chain: A, B; Fragment: Extracellular Domain (Residues 23-646); Synonym: P185erbb2, Neu Proto-Oncogene, C-Erbb-2, Tyrosine Kinase-Type Cell Surface Receptor Her2, Mln 19; Ec: 2.7.1.112; Engineered: Yes; Mol_id: 2; Molecule: Pertuzumab Fab Light Chain; Chain: C, E; Engineered: Yes; Mol_id: 3; Molecule: Pertuzumab Fab Heavy Chain; Chain: D, F; Engineered: Yes > BMA > 27406.16 > 27406 > http://www.ncbi.nlm.nih.gov/Structure/MMDB/mmdb.shtml > http://www.ncbi.nlm.nih.gov/Structure/mmdb/mmdbsrv.cgi?uid=27406 > 439680 1 $$$$